In regard to Van den Bruele AB et al. Management of ipsilateral breast tumor recurrence following breast conservation surgery: a comparative study of re-conservation vs mastectomy. Breast Cancer Res Treat. 2021 May;187(1):105–112. doi:10.1007/s10549-020-06080-9. Epub 2021 Jan 12. PMID: 33433775; PMCID: PMC8068641 Jean-Michel Hannoun-LeviCsaba PolgarOn behalf of the Breast Cancer Working Group of the GEC-ESTRO Letter to the Editor 06 August 2021 Pages: 3 - 4
Breast cancer resistance mechanisms: challenges to immunotherapy Ann HannaJustin M. Balko Review 28 July 2021 Pages: 5 - 17
Turning scientific serendipity into discoveries in breast cancer research and treatment: a tale of PhD students and a 50-year roaming tamoxifen team V. Craig Jordan Review Open access 16 August 2021 Pages: 19 - 38
The frequency and clinical significance of DNA polymerase beta (POLβ) expression in breast ductal carcinoma in situ (DCIS) Abdulbaqi Al-KawazReem AliEmad A. Rakha Preclinical study Open access 18 August 2021 Pages: 39 - 51
Investigating the role of endogenous estrogens, hormone replacement therapy, and blockade of estrogen receptor-α activity on breast metabolic signaling Alana A. ArnoneJ. Mark ClineKatherine L. Cook Preclinical study Open access 26 August 2021 Pages: 53 - 67
A randomized controlled trial of metformin in women with components of metabolic syndrome: intervention feasibility and effects on adiposity and breast density Edgar TapiaDiana Evelyn Villa-GuillenH-H. Sherry Chow Clinical trial 12 August 2021 Pages: 69 - 78
Brief relaxation training is associated with long-term endocrine therapy adherence among women with breast cancer: post hoc analysis of a randomized controlled trial Molly E. ReamEmily A. WalshMichael H. Antoni Clinical trial 19 August 2021 Pages: 79 - 88
Effects of exercise in breast cancer patients: implications of the trials within cohorts (TwiCs) design in the UMBRELLA Fit trial Roxanne GalEvelyn M. MonninkhofAnne M. May Clinical trial Open access 24 August 2021 Pages: 89 - 101
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9) Rosalba TorrisiRaffaella PalumboArmando Santoro Clinical trial 27 August 2021 Pages: 103 - 109
Hormone receptor-positive breast cancer and black race: does sex matter? Mariam F. EskanderYaming LiSamilia Obeng-Gyasi Epidemiology 12 August 2021 Pages: 111 - 119
Myosteatosis at diagnosis is adversely associated with 2-year survival in women with estrogen receptor-negative metastatic breast cancer Patricia SheeanSandra Gomez-PerezPatricia Robinson Epidemiology 13 August 2021 Pages: 121 - 132
Cardiac risk stratification of breast cancer patients in a cardio-oncology clinic Peter G. DoukasRuchi N. PatelNausheen Akhter Epidemiology 14 August 2021 Pages: 133 - 142
Multilevel predictors of guideline concordant needle biopsy use for non-metastatic breast cancer Anja ZgodicJan M. EberthMatthew F. Hudson Epidemiology 17 August 2021 Pages: 143 - 153
HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer Luciana de Moura LeiteMarcelle Goldner CescaNoam Falbel Pondé Epidemiology 18 August 2021 Pages: 155 - 163
Cholesterol lowering drug use and breast cancer survival: the Multiethnic Cohort Study Nafeesa MoksudLenora W. M. LooIona Cheng Epidemiology Open access 30 August 2021 Pages: 165 - 173